I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 13 studies | 22% ± 7% | |
| endothelial cell | 10 studies | 24% ± 7% | |
| pericyte | 7 studies | 17% ± 1% | |
| enterocyte | 6 studies | 22% ± 3% | |
| endothelial cell of artery | 6 studies | 24% ± 5% | |
| epithelial cell | 5 studies | 43% ± 20% | |
| basal cell | 5 studies | 28% ± 12% | |
| connective tissue cell | 5 studies | 20% ± 3% | |
| pancreatic A cell | 4 studies | 34% ± 24% | |
| plasma cell | 4 studies | 29% ± 12% | |
| goblet cell | 4 studies | 26% ± 9% | |
| adipocyte | 4 studies | 21% ± 5% | |
| ionocyte | 3 studies | 26% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 3% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 23% ± 5% | |
| glomerular endothelial cell | 3 studies | 23% ± 1% | |
| ciliated cell | 3 studies | 33% ± 6% | |
| gamma-delta T cell | 3 studies | 21% ± 3% | |
| type I pneumocyte | 3 studies | 22% ± 3% | |
| GABAergic neuron | 3 studies | 33% ± 5% | |
| glutamatergic neuron | 3 studies | 45% ± 6% | |
| oligodendrocyte | 3 studies | 18% ± 3% | |
| astrocyte | 3 studies | 17% ± 0% | |
| interneuron | 3 studies | 29% ± 11% | |
| hepatocyte | 3 studies | 39% ± 30% | |
| oligodendrocyte precursor cell | 3 studies | 20% ± 2% |
